GSK PLC-SPON ADR (GSK) Institutional Ownership Changes & 13F Activity

GSK PLC-SPON ADR (GSK) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Dodge & Cox Stock Fund, Renaissance Technologies LLC, Causeway Capital Management, Kahn Brothers Group, and Hillman Value Fund.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2022Dodge & Cox Stock FundBuy6,348,96364,932,952$2,281,743,933
Q4 2022Renaissance Technologies LLCSell-3,016,9066,337,151$222,687
Q4 2022Tweedy, Browne Co All Funds (US)Buy139,327139,327$4,896
Q4 2022Causeway Capital ManagementBuy53,489237,033$8,329,323
Q4 2022Ariel Appreciation FundBuy15,727185,288$6,511,020
Q4 2022Sequoia Financial AdvisorsBuy10,92010,920$383,729
Q4 2022First Eagle U.S. ValueBuy9,90159,460$2,089,410
Q4 2022Hillman Value FundSell-6,099237,879$8,359,068
Q3 2022Dodge & Cox Stock FundBuy58,583,98958,583,989$1,724,127
Q3 2022Renaissance Technologies LLCBuy9,354,0579,354,057$275,290
Q3 2022Hillman Value FundBuy243,978243,978$7,181
Q3 2022Ariel Appreciation FundBuy169,561169,561$4,990
Q3 2022Causeway Capital ManagementSell-74,619183,544$5,402
Q3 2022First Eagle U.S. ValueBuy49,55949,559$1,459
Q2 2022Causeway Capital ManagementBuy258,163258,163$11,238

Frequently asked questions about GSK activity

  • Which institutional owners are buying GSK?

    Institutional owners buying GSK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in GSK activity?

    "Buy" means an investor increased their reported position in GSK compared to the prior reporting period. This reflects growing exposure to GSK PLC-SPON ADR (GSK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in GSK increasing?

    Institutional interest in GSK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related GSK insights